PMID: 9434094Jan 20, 1998Paper

Cloning and characterization of the murine homologue of the rat/human MRC OX-2 gene

Biochimica Et Biophysica Acta
Z ChenReginald Gorczynski

Abstract

A 350 bp amplicon, obtained by PCR-select subtractive hybridization from RNA derived from mesenteric lymph nodes (MLN) cells from mice pre-immunized with allogeneic lymphocytes 36hrs prior to receiving donor-specific skin grafts, and showing > 98% homology with a published sequence for the rat MRC OX-2 gene, was used as a hybridization probe to screen a cDNA library constructed from adult mouse MLN treated in the same fashion. Several clones were identified which, on DNA sequence analysis, predicted a 218 amino acid protein showing significant homology with the rat and human MRC OX-2 gene product.

Citations

Jun 16, 2005·Molecular Immunology·Zhiqi ChenReginald M Gorczynski
Jun 19, 2010·Nucleic Acids Research·Zhiqi ChenReginald M Gorczynski
Jul 20, 2002·Transplantation·R M GorczynskiJ Lei
Feb 11, 2012·The Journal of Comparative Neurology·Kalpana ShrivastavaLaia Acarin
Dec 1, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R M GorczynskiJ Hu
Feb 28, 2014·Advanced Healthcare Materials·Yoon Kyung KimWendy F Liu
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R M GorczynskiD Clark
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shuli ZhangJoseph H Phillips
Jul 14, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reginald M GorczynskiIvo Boudakov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.